Skin cancer drug news boosts Bristol shares
Posted by Reuters: Business News on June 7, 2010
NEW YORK/LONDON (Reuters) – Bristol-Myers Squibb Co’s shares rose more than 8 percent on Monday after news over the weekend that its experimental drug ipilimumab extended survival in patients with deadly skin cancer.
